More than 100,000 bottles of Amazon-branded acetaminophen have been recalled nationwide after customers complained of discolored tablets, even as a health review found no impact on safety.
Aurobindo Pharma USA Inc. pulled the painkiller from sale on September 18. The voluntary recall covers Amazon Extra Strength acetaminophen 500mg caplets sold across the country in 200-count, 500-count, and 1,000-count bottles.
The US Sun reported that the action followed consumer complaints about tablet discoloration in specific lots. Amazon has already started contacting buyers and offering refunds once they confirm they threw the pills away.
An Amazon spokesperson told PEOPLE the recall was voluntary and came after “reports of tablet discoloration in the affected lots.” The company said the effort is being run “in coordination” with pharmaceutical manufacturer Aurohealth and the Food and Drug Administration.
"reports of tablet discoloration in the affected lots."
Shoppers who bought the medicine can check lot numbers at amazon.com/your-product-safety-alerts. Impacted customers get a refund after they confirm disposal.
The scale is not small. In total, more than 100,000 bottles are involved.
That breaks down to 14,640 of the 200-count bottles from lot ACD125040A, with an expiration date of Sept. 30, 2027. Another 90,456 of the 500-count bottles span several lots: ACD124036A and ACD124030A (expiring Sept. 30, 2027), ACD124042A (Oct. 31, 2027), ACD124048B (Nov. 30, 2027), and ACD125010A (Feb. 29, 2028). A further 7,836 of the 1,000-count bottles from lot ACD124048A expire Nov. 30, 2027.
All of it is the same product: Amazon-branded Extra Strength acetaminophen, 500mg caplets. The pills were sold nationwide.
A Health Hazard Evaluation concluded the discoloration does not change the medication’s safety or efficacy. So far, no adverse events or other issues have been reported.
The FDA’s enforcement report on the recall did not assign a classification level. Federal recalls are typically sorted into one of three classes based on health risk. This one carried no such label in the report described.
That leaves a plain fact on the table: customers opened bottles of a common fever-and-pain medicine and found tablets that did not look right. The manufacturer and the retailer moved to pull the stock. Regulators signed off on a finding that the color change itself does not make the drug unsafe. No one has reported getting sick from it.
Still, medicine is not a casual product. People buy acetaminophen because they trust the dose, the seal, and the appearance of what they put in their bodies. Discolored tablets reaching kitchen cabinets is a quality-control failure, full stop, even when the follow-up review says the chemistry still works.
Amazon is handling the consumer end. The company has reached out to people who purchased the affected lots. Refunds follow once the buyer confirms the bottles were disposed of. Lot details and safety alerts sit on Amazon’s product-safety page.
Aurobindo Pharma USA Inc. issued the recall. Aurohealth is named as the pharmaceutical manufacturer working with Amazon and the FDA on the voluntary pull. The FDA confirmed the bottles went out nationwide in the three sizes listed above.
No named executives have spoken publicly in the available record. The Amazon statement went out through a spokesperson. No count of individual discoloration complaints has been released, and no city-by-city breakdown of sales has been provided.
What is clear is the timeline. The recall went out September 18. The lots carry expiration dates running from late 2027 into early 2028. Consumers who still have the bottles are being told to check the lot codes, stop using the product if it matches, and seek the refund path Amazon has set up.
When a household staple like acetaminophen shows up looking wrong, families should not have to play quality inspector. Manufacturers and big retailers own that standard, and they owe customers a clean bottle every time.